Renaissance Technologies’s Disc Medicine IRON Stock Holding History
Bought
Maintained
Sold
Other funds holding IRON
RCM
VPC
AVLSA
Renaissance Technologies's IRON Position: Q2 2026 in Review
Renaissance Technologies sold out of Disc Medicine (IRON) in Q2 2026, closing a stake of 31,820 shares — an estimated $2.03M sold.
Renaissance Technologies first reported a position in IRON in Q4 2021 and held it in 16 quarters. The position peaked at $9.49M in Q1 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.
- Renaissance Technologies reported no remaining Disc Medicine position as of Q2 2026 after selling out during the quarter.
- Renaissance Technologies sold 31,820 Disc Medicine shares in Q2 2026, an estimated $2.03M.
- Renaissance Technologies first reported a position in Disc Medicine in Q4 2021 and held it in 16 quarters.
- Renaissance Technologies's Disc Medicine position peaked at $9.49M in Q1 2025.
- 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.